We are live on ! Find out more
IHI icon

iShares US Medical Devices ETF

559 hedge funds and large institutions have $2.87B invested in iShares US Medical Devices ETF in 2021 Q2 according to their latest regulatory filings, with 63 funds opening new positions, 172 increasing their positions, 231 reducing their positions, and 65 closing their positions.

New
Increased
Maintained
Reduced
Closed

3% less first-time investments, than exits

New positions opened: 63 | Existing positions closed: 65

1% less funds holding

Funds holding: 566559 (-7)

17% less funds holding in top 10

Funds holding in top 10: 2319 (-4)

22% less call options, than puts

Call options by funds: $21M | Put options by funds: $26.9M

26% less repeat investments, than reductions

Existing positions increased: 172 | Existing positions reduced: 231

26% less capital invested

Capital invested by funds: $3.87B → $2.87B (-$995M)

44.87% less ownership

Funds ownership: 282.27%237.4% (-45%)

Holders
559
Holders Change
-7
Holders Change %
-1.24%
% of All Funds
9.73%
Holding in Top 10
19
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-17.39%
% of All Funds
0.33%
New
63
Increased
172
Reduced
231
Closed
65
Calls
$21M
Puts
$26.9M
Net Calls
-$5.93M
Net Calls Change
+$1.21M
Name Holding Trade Value Shares
Change
Change in
Stake
Brown Advisory
276
Brown Advisory
Maryland
$765K +$46.8K +810 +7%
SEIA
277
Signature Estate & Investment Advisors
California
$750K -$415K -7,176 -37%
GLA
278
Good Life Advisors
Pennsylvania
$748K -$7.98K -138 -1%
MSFS
279
Main Street Financial Solutions
Pennsylvania
$743K -$64.2K -1,110 -8%
PWW
280
Pettyjohn Wood & White
Virginia
$743K -$8.68K -150 -1%
FWSM
281
First Wilshire Securities Management
California
$740K
NP
282
NorthRock Partners
Minnesota
$723K +$3.48M +60,108 +500%
SA
283
Strategic Advisors
New York
$713K +$9.37K +162 +1%
OGC
284
Oak Grove Capital
New Hampshire
$703K -$69.4K -1,200 -9%
GIA
285
Goodwin Investment Advisory
Georgia
$702K -$2.67M -46,092 -80%
GGI
286
GPM Growth Investors
Michigan
$696K +$669K +11,568 New
NFG
287
Next Financial Group
Texas
$691K -$570K -9,858 -46%
LWP
288
Legacy Wealth Planning
Nevada
$691K +$8.68K +150 +1%
WG
289
Welch Group
Alabama
$688K -$26K -450 -4%
GRP
290
Global Retirement Partners
California
$669K -$28.8K -498 -4%
TCWM
291
Total Clarity Wealth Management
Illinois
$668K +$99.2K +1,716 +18%
KM
292
Kalos Management
Georgia
$665K +$2.85M +49,254 +417%
PFA
293
Plotkin Financial Advisors
Maryland
$655K +$629K +10,878 New
Koshinski Asset Management
294
Koshinski Asset Management
Illinois
$652K -$213K -3,690 -25%
AWA
295
ARS Wealth Advisors
Florida
$650K
M&T Bank
296
M&T Bank
New York
$639K -$10.1M -174,750 -94%
HFA
297
High Falls Advisors
New York
$636K -$5.78M -99,906 -90%
LJAC
298
L.J. Altfest & Co
New York
$636K +$611K +10,572 New
SAM
299
Strategy Asset Managers
California
$627K +$218K +3,774 +57%
MSAM
300
Moloney Securities Asset Management
Missouri
$623K -$2.43K -42 -0.4%

IHI Hedge Fund Activity: Q2 2021 in Review

559 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in iShares US Medical Devices ETF (IHI) for Q2 2021, worth a combined $2.87B — down 26% from $3.87B a quarter earlier.

Sellers outnumbered buyers: 65 funds closed out of IHI and 63 opened new positions — a net loss of 2 holders — while 231 trimmed existing stakes and 172 added.

The largest buyer was TD Asset Management, adding an estimated $97.4M. The largest seller was Envestnet Asset Management, cutting an estimated $364M.

  • 559 institutional investors held iShares US Medical Devices ETF (IHI) as of Q2 2021, down from 566 in Q1 2021.
  • Funds reported $2.87B of iShares US Medical Devices ETF stock for Q2 2021, down 26% quarter-over-quarter.
  • 63 funds opened new iShares US Medical Devices ETF positions in Q2 2021 and 65 closed out, a net change of -2 holders.
  • The largest iShares US Medical Devices ETF buyer in Q2 2021 was TD Asset Management, an estimated $97.4M added.
  • The largest iShares US Medical Devices ETF seller in Q2 2021 was Envestnet Asset Management, an estimated $364M sold.

Based on aggregated 13F filings for Q2 2021.